Nemera breaks ground in Brazil through Milfra acquisition

Nemera today announced that they have entered into an agreement to acquire Milfra. Milfra, based in ...

Cristália launches Lunah in Brazilian market

Cristália, one of the largest pharmaceutical companies in Brazil, launched LUNAH, a preservative-fre...

Nemera's RetroNose enhances therapeutic efficacy of nasal treatments

The number of applications through the nasal route is expanding, either for local treatments (e.g. c...

New: Twisting applicator for Sof’Bag by Nemera

The dermal application of potent gel or cream drugs can be problematic when rubbing is done with the...

Nemera's high performance pump eAdvancia

Nemera's high performance pump Advancia® is combined with a reusable electronic add-on to improve patient compliance.

e-Novelia wins the ‘Excellence in Pharma: Drug Delivery Devices’ award at CPhI Worldwide 2018

On October 9th, during the CPhI Pharma Awards Gala, e-Novelia®, Nemera’s electronic add-on for ophth...

Nemera receives Drug Manufacturing Authorization for its Neuenburg plant, in Germany

The certification gives the manufacturing plant the approval to handle, assemble, sterilize and stor...

RDD – Respiratory drug delivery conference, April 17-21, 2016

Phoenix, AZ, US

NEMERA will be SPEAKER and EXHIBITOR at CphI Worldwide

Teaser Nemera

Nemera, we put the patient first

Nemera's Safe'n'Sound responds to pharma and user needs

Providing premium safety, Safe'n'Sound is a Nemera's solution to avoid needlestick injuries offering...

A new 70 µl dose is available for the SP270+ pump!

The SP270+ pump range, Nemera’s standard platform for nasal sprays, is now available with a new 70µl...

NEMERA will be EXHIBITOR and launching SAFELIA autoinjector concept at PDA The Universe of Pre-filled Syringes and Injection Devices

Nemera announces its participation in the European Cupido Project

Nemera is proud to contribute to the EU-funded project Cupido, started in February 2017. It proposes...

Pulmonary

Inhalation devices Recognized expertise in developing and manufacturing respiratory devices such as...

Ophthalmic

Preservative-free multidose eyedropper. Nemera is a pioneer in preservative-free solutions and devices.

Dermal & Transdermal

Dispensers and airless systems Dispensing systems for topical and systemic dermal applications, air...

Parental

Injectable devices and safety systems Recognized expertise in developing and manufacturing parenter...

Nasal, Buccal & Auricular

Sprays and pumps Extensive range of pumps, valves and applicators.

The UK has approved a new drug product for glaucoma treatment, delivered with Novelia, Nemera's multidose preservative-free eyedropper

The Novelia® system is the first and only preservative-free multidose eyedropper UK-approved for a g...

Nemera has won the ‘Best New Product’ category at the annual INTERPHEX Awards

INTERPHEX and a team of industry experts select Nemera (booth 1636) as winner for this year’s exhib...

Safelia 1ml and 2.25ml autoinjectors designed to be patient and syringe friendly

Nemera’s new generation 2-step autoinjector platforms are suitable for fluid to highly viscous injec...

Nemera’s preservative-free multidose eye dropper Novelia approved for Santen’s Cosopt for Glaucoma treatments

Nemera’s multidose eye dropper Novelia has been approved for the preservative-free formulation Cosop...

Novelia is now commercialized for the first time for glaucoma in Latin America!

Our preservative-free multidose eyedropper has been launched in Paraguay with different formulations (branded OFTALMICA)

Dermal transdermal brochure

Nasal, bucal, auricular brochure

Brochures

Catalogs

Nemera news mag

Nemera Exhibitions